UK markets closed

Lipocine Inc. (LPCN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.6800-0.0200 (-0.43%)
At close: 04:00PM EDT
4.5600 -0.12 (-2.56%)
After hours: 06:04PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
-2,851
-2,851
500
16,141
0
Cost of revenue
10,175
10,175
8,557
7,666
9,748
Gross profit
-13,026
-13,026
-8,057
8,475
-9,748
Operating expenses
Research development
7,468
-
-
-
-
Selling general and administrative
4,905
4,905
4,062
5,330
8,248
Total operating expenses
4,905
4,905
4,062
5,330
8,248
Operating income or loss
-17,931
-17,931
-12,119
3,146
-17,996
Interest expense
0
0
27.098
203.292
386.618
Total other income/expenses net
212.69
212.69
815.94
-3,644
-2,657
Income before tax
-16,351
-16,351
-10,758
-634.199
-20,965
Income tax expense
0.755
0.755
0.681
0.2
0.2
Income from continuing operations
-16,352
-16,352
-10,759
-634.399
-20,965
Net income
-16,352
-16,352
-10,759
-634.399
-20,965
Net income available to common shareholders
-16,352
-16,352
-10,759
-634.399
-20,965
Basic EPS
-3.09
-
-2.06
-0.17
-6.46
Diluted EPS
-3.21
-
-2.15
-0.17
-6.46
Basic average shares
5,221
-
5,232
5,114
3,276
Diluted average shares
5,223
-
5,256
5,114
3,276